New weight loss pills could become long term obesity treatments

Email: online@newsofbahrain.com

NEW YORK: Medical science has reached a potential turning point in the fight against obesity with the development of a daily pill designed to keep patients slim for life.

Moving beyond the era of weekly injections, Orforglipron developed by the US company Eli Lilly and known as Foundayo focuses on ‘metabolic reprogramming.’ Instead of just suppressing appetite temporarily, the drug targets the biological mechanisms that control the body’s long-term weight ‘set point.’

Researchers indicate that the pill works by mimicking the effects of a high-speed metabolism, allowing the body to burn calories more efficiently while signaling the brain to maintain a lower fat percentage.

One of the most significant advantages of Foundayo is the prevention of the ‘yo-yo effect’; early data shows that users do not experience the rapid weight gain typically seen when stopping other weight-loss treatments. By providing a consistent, easy-to-take daily dose, this Eli Lilly breakthrough could transform weight management from a constant struggle into a manageable, long-term health routine.